Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 20/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 19/20 | 0.39 |
| ▸ | IKZF3 | Q9UKT9 | 4/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | IL1B | P01584 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29079608 | 0.82 | CRBN (0.39) | CRBNDDB1IKZF3TNFIL1B | |
| SCHEMBL29079658 | 0.80 | DDB1 (0.42) | CRBNDDB1IKZF3TNFIL1B | |
| SCHEMBL29768089 | 0.80 | DDB1 (0.42) | CRBNDDB1IKZF3TNFIL1B | |
| SCHEMBL29767997 | 0.79 | CRBN (0.41) | CRBNDDB1IKZF3TNFIL1B | |
| SCHEMBL29079558 | 0.78 | CRBN (0.40) | CRBNDDB1IKZF3TNFIL1B | |
| Hydrochloric Acid SCHEMBL29079654 | 0.77 | CRBN (0.40) | CRBNDDB1IKZF3TNFIL1B | |
| SCHEMBL29079635 | 0.75 | CRBN (0.41) | CRBNDDB1IKZF3TNFALDH1A1 | |
| SCHEMBL29768100 | 0.75 | CRBN (0.41) | CRBNDDB1IKZF3TNFALDH1A1 | |
| SCHEMBL31134471 | 0.73 | DDB1 (0.47) | CRBNDDB1IKZF3TNFIL1B | |
| SCHEMBL29079566 | 0.72 | CRBN (0.50) | CRBNDDB1IKZF3TNFIL1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116648248-A | Aromatic compound, pharmaceutical composition containing same and application thereof | 成都茵创园医药科技有限公司 | 2023-08-25 | — | — | CN | disclosed |